Satellos Bioscience (MSLE) Retained Earnings (2023 - 2026)

Satellos Bioscience (MSLE) has 4 years of Retained Earnings data on file, last reported at -$91.7 million in Q1 2026.

• On a quarterly basis, Retained Earnings changed N/A year-over-year to -$91.7 million in Q1 2026; TTM through Mar 2026 was -$91.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $82.0 million, up 243.56% from the prior year.
• Retained Earnings for Q1 2026 stood at -$91.7 million, down from $82.0 million in the prior quarter.
• Over the last five years, Retained Earnings for MSLE reached as high as $82.0 million in Q4 2025 and fell as low as -$91.7 million in Q1 2026.
• Historically, Retained Earnings has averaged -$24.7 million across 4 years, with a median of -$44.5 million in 2023.
• Across the five-year window, Retained Earnings plunged 55.1% in 2024 and surged 251.46% in 2025, its largest moves.
• Year by year, Retained Earnings stood at -$34.9 million in 2023, then plunged by 55.1% to -$54.1 million in 2024, then jumped by 251.46% to $82.0 million in 2025, then tumbled by 211.92% to -$91.7 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$91.7 million in Q1 2026, $82.0 million in Q4 2025, and -$54.1 million in Q4 2024.